These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24327765)

  • 21. Short-term effect of upstream administration in comparison to deferred injection of tirofiban on patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Jia Z; Guo M; Zhang YQ; Liang HQ; Song Y
    J Interv Cardiol; 2013 Aug; 26(4):332-9. PubMed ID: 23844823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial.
    Valgimigli M; Tebaldi M; Campo G; Gambetti S; Bristot L; Monti M; Parrinello G; Ferrari R;
    JACC Cardiovasc Interv; 2012 Mar; 5(3):268-77. PubMed ID: 22440491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI.
    Hermanides RS; van Werkum JW; Ottervanger JP; Breet NJ; Gosselink AT; van Houwelingen KG; Dambrink JH; Hamm C; ten Berg JM; van 't Hof AW;
    Catheter Cardiovasc Interv; 2012 May; 79(6):956-64. PubMed ID: 22162050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
    Xia JG; Qu Y; Shen H; Liu XH
    Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
    Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
    Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
    Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
    Pride YB; Mohanavelu S; Zorkun C; Kunadian V; Giugliano RP; Newby LK; Braunwald E; Califf RM; Harrington RA; Gibson CM;
    JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction.
    Fu XH; Hao QQ; Jia XW; Fan WZ; Gu XS; Wu WL; Hao GZ; Li SQ; Jiang YF; Geng W
    Chin Med J (Engl); 2008 Mar; 121(6):522-7. PubMed ID: 18364139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D; Zhong W; Fan L; Chen L
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial.
    Bolognese L; Falsini G; Liistro F; Angioli P; Ducci K; Taddei T; Tarducci R; Cosmi F; Baldassarre S; Burali A
    J Am Coll Cardiol; 2006 Feb; 47(3):522-8. PubMed ID: 16458130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of the coronary thrombus burden with all-cause mortality and major cardiac events in ST-segment elevation myocardial infarction patients treated with tirofiban.
    Tatlisu MA; Kaya A; Keskin M; Uzman O; Borklu EB; Cinier G; Hayiroglu MI; Eren M
    Coron Artery Dis; 2016 Nov; 27(7):543-50. PubMed ID: 27341666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1121-1132. PubMed ID: 32078096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
    Marzocchi A; Manari A; Piovaccari G; Marrozzini C; Marra S; Magnavacchi P; Sangiorgio P; Marinucci L; Taglieri N; Gordini G; Binetti N; Guiducci V; Franco N; Reggiani ML; Saia F;
    Eur Heart J; 2008 Dec; 29(24):2972-80. PubMed ID: 18940887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of manual thrombectomy on myocardial reperfusion as assessed by ST-segment resolution in STEMI patients treated by primary PCI.
    Messas N; Hess S; El Adraa A; Ristorto J; Goïorani F; Brocchi J; Radulsecu B; Jesel L; Zupan M; Ohlmann P; Morel O
    Arch Cardiovasc Dis; 2014 Dec; 107(12):672-80. PubMed ID: 25219758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein IIb/IIIa inhibitor (tirofiban) in acute ST-segment elevation myocardial infarction.
    Fang CC; Jao YT; Chen Y; Yu CL; Wang SP
    Angiology; 2009; 60(2):192-200. PubMed ID: 18445614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
    Kurt IH; Demirkol S; Ünal I; Batur MK
    Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon.
    Hu X; Wang W; Ye J; Lin Y; Yu B; Zhou L; Zhou Y; Dong H
    Biomed Pharmacother; 2021 Nov; 143():112196. PubMed ID: 34560551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
    Van't Hof AW; Ten Berg J; Heestermans T; Dill T; Funck RC; van Werkum W; Dambrink JH; Suryapranata H; van Houwelingen G; Ottervanger JP; Stella P; Giannitsis E; Hamm C;
    Lancet; 2008 Aug; 372(9638):537-46. PubMed ID: 18707985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
    Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
    Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.